Stephen A. Rappaport

Book review: Evaluating Residential Facilities

Stephen A. Rappaport, 1999 .

The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer’s disease

Stephen A. Rappaport, S. Leurgans, D. Bennett, 2013, Alzheimer's Research & Therapy.

Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extension Trial.

Stephen A. Rappaport, P. Arsenault, C. Rauschkolb, 2015, Clinical therapeutics.

The Value of Age and Severity as Predictors of Costs in Geriatric Head Trauma Patients

Stephen A. Rappaport, R. Saywell, J. Woods, 1989, Journal of the American Geriatrics Society.

A randomized, double-blind, placebo-controlled tolerability study of intramuscular aripiprazole in acutely agitated patients with Alzheimer's, vascular, or mixed dementia.

Stephen A. Rappaport, R. Mcquade, D. Oren, 2009, Journal of the American Medical Directors Association.

Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia.

Stephen A. Rappaport, A. Breier, M. Dysken, 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.